Hanson McClain Advisors »

Verve Therapeutics shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2023-09-30 $14 1 14.00
2023-06-30 $1.8k 98 18.76
2023-03-31 $1.3k 87 14.43